跳至主要内容
临床试验/IRCT20240124060794N1
IRCT20240124060794N1尚未招募3 期

Investigating the effect of spirulina algae supplement on the quality of life, speed of nerve pulse transmission and antioxidant status of patients with progressive-recovery multiple sclerosis.

Esfahan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Patients with MS of RRMS type
  • Age of patients 18-50 years
  • Receiving immunosuppressive drugs for at least three months
  • Not taking multivitamin supplements (except vitamin D) at least 3 months before participating in the study
  • Having an Extended Disability Status Scale (EDSS) between 0 and 6

排除标准

  • Presentation of acute forms of liver and biliary system disease and pancreatic disease
  • History of viral diseases
  • Chronic renal or cardiovascular disease and diseases where oxidative stress is considered as their etiology
  • Obese patients (body mass index (BMI) = 30 kg/m2), malnourished patients (BMI < 18.5 kg/m2)
  • Dependence on drugs, smoking or alcohol
  • Not taking anticoagulants
  • Breastfeeding
  • Hospitalized
  • Autoimmune diseases that affect the Th1/Th2 balance
  • Diseases in which oxidative stress is proposed as their etiology

研究者

相似试验